Deep Tech

It topped global and China rankings in the first quarter, while new products strengthened its category lead during the 618 shopping festival.

A small float helped amplify the stock’s swing, turning its IPO into a test of investor sentiment.

The drug developer has no approved products or revenue yet, but the IPO could extend its cash runway by nearly six years.

SenseTime co-founder Wang Xiaogang discusses the complexity of embodied intelligence through the lens of ACE Robotics.

The listing will test investor appetite for decision intelligence as the AI narrative reaches a high point.

The move reflects pressure to lower costs and compete across broader price bands.

The oil price surge from the US-Iran crisis gives fresh impetus to efforts to boost domestic energy supply.

The company expects conversations to become the starting point for AI workflows.